+1 7755157689


A 16-Year-Old Girl with Hereditary Hemorrhagic Telangiectasia

A 16-year-old girl was admitted to the hospital with severe ab dominal pain that could not be relieved. She was initially misdi agnosed as enterocolitis and did not improve after symptomatic treatment, the rupture of the spleen and massive blood accumu lation in the abdominal cavity were detected by ultrasonography and CT (Figure 1).

Severe and Transient Thrombocytopenia Following the Third Dose of COVID-19 Vaccine (mRNA-1273): A Case Report

Autoimmune thrombocytopenia after coronavirus disease 2019 (COVID-19) vaccination rarely occurs as adverse events and usu ally occurs after the first or second dose. We report the case of an 89-year-old woman who rapidly developed purpura with severe thrombocytopenia following the third dose of the mRNA-1273 Moderna vaccine. She had no adverse events following the first and second doses of the BNT162b2 Pfizer-BioNTech vaccine, but purpura with petechiae on the left upper chest and both upper and lower extremities appeared the day after the third dose with the mRNA-1273 vaccine.

The Superiority of Amniotic Membrane in the Treatment of Aplasia Cutis Congenita

1.1. Introduction: Aplasia cutis congenital (ACC) is a heteroge neous group of disorders that share a common feature of focal skin loss. In most cases, this is limited to the scalp, also involve other parts of the body. (ACC) is a heterogeneous group of disorders whose common characteristic is focal absence of skin. In the ma jority of instances this is limited to the scalp, although other areas of the body may also be involved. It is characterized by a lack of skin and adjacent tissues, and it can extend into underlying tis sues, such as muscle tissue and bone, that can be underdeveloped or even absent. ACC can be life-threatening in severe cases. Both conservative and surgical approaches carry risks, and the timing of surgery remains controversial.

error: Content is protected !!